Guillain-Barré syndrome

GPTKB entity

Statements (56)
Predicate Object
gptkbp:instanceOf autoimmune disease
neurological disorder
gptkbp:affects adults
children
elderly
peripheral nervous system
gptkbp:alsoKnownAs gptkb:GBS
gptkbp:category acute polyneuropathy
demyelinating disease
rare disease
gptkbp:cause immune system attacks peripheral nerves
gptkbp:complication respiratory failure
autonomic dysfunction
gptkbp:diagnosedBy lumbar puncture
nerve conduction studies
gptkbp:field neurology
gptkbp:firstDescribed 1916
gptkbp:frequency rare
gptkbp:gender slightly more common in males
https://www.w3.org/2000/01/rdf-schema#label Guillain-Barré syndrome
gptkbp:ICD-10_code G61.0
gptkbp:incidence 1-2 per 100,000 per year
gptkbp:mortalityRate low
gptkbp:namedAfter gptkb:Georges_Guillain
gptkb:Jean_Alexandre_Barré
gptkbp:notableCase Franklin D. Roosevelt (disputed)
gptkbp:onset acute
gptkbp:prognosis usually good with treatment
gptkbp:relatedTo gptkb:Miller_Fisher_syndrome
gptkb:chronic_inflammatory_demyelinating_polyneuropathy
gptkbp:restored weeks to months
gptkbp:riskFactor recent infection
recent vaccination (rare)
gptkbp:subspecies gptkb:Miller_Fisher_syndrome
gptkb:acute_inflammatory_demyelinating_polyneuropathy
gptkb:acute_motor-sensory_axonal_neuropathy
gptkb:acute_motor_axonal_neuropathy
gptkbp:symptom paralysis
muscle weakness
numbness
tingling
gptkbp:treatment supportive care
intravenous immunoglobulin
plasmapheresis
gptkbp:triggeredBy gptkb:COVID-19
gptkb:Zika_virus
gptkb:Campylobacter_jejuni
gptkb:influenza_virus
infection
gptkbp:bfsParent gptkb:EMG
gptkb:Nervous_system
gptkb:Zika_Virus
gptkb:GBS
gptkb:Johnson_&_Johnson_COVID-19_vaccine
gptkb:Axon
gptkbp:bfsLayer 5